Literature DB >> 20811047

The phenotype of Severe Early Childhood Onset Retinal Dystrophy (SECORD) from mutation of RPE65 and differentiation from Leber congenital amaurosis.

Richard G Weleber1, Michel Michaelides, Karmen M Trzupek, Niamh B Stover, Edwin M Stone.   

Abstract

PURPOSE: To describe in detail the characteristic clinical phenotype and electrophysiological features of Severe Early Childhood Onset Retinal Dystrophy (SECORD) caused by mutation of RPE65.
METHODS: Ophthalmological examination, color fundus photography, visual field testing, detailed electrophysiological assessment, and screening of RPE65 were undertaken in five subjects. Selected patients also had spectral domain optical coherence tomography.
RESULTS: All five patients had life-long, extremely poor night vision. Variable degrees of nystagmus were present; three cases lacked nystagmus at the time of assessment. Bilateral disc drusen were evident in three subjects. While case 1 had an undetectable electroretinogram and features supporting a diagnosis of Leber congential amaurosis (LCA) as an infant, her level of acuity and function into the second decade of life was more consistent with SECORD. In two cases, both vision and electrophysiological responses were seen to improve into the second decade of life. The objective demonstration of improved retinal function over time, with electrophysiological testing, has not been previously reported. Cases 4 and 5 had evidence of fine white retinal dots. The authors propose that these represent abnormal accumulations of retinyl esters, as has been demonstrated in animal models, and has also been observed as lipid droplets within the retinal pigment epithelium (RPE). These white dots were seen to fade with time in the patients and were replaced by RPE changes.
CONCLUSIONS: The identification of patients with mutations in RPE65 has attained greater significance now that gene replacement trials have begun. The features presented in this article assist in the recognition of this form of LCA/SECORD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20811047     DOI: 10.1167/iovs.10-6106

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  29 in total

Review 1.  Gene therapy for Leber congenital amaurosis: advances and future directions.

Authors:  Robert B Hufnagel; Zubair M Ahmed; Zélia M Corrêa; Robert A Sisk
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-29       Impact factor: 3.117

2.  Longitudinal clinical course of three Japanese patients with Leber congenital amaurosis/early-onset retinal dystrophy with RDH12 mutation.

Authors:  Kazuki Kuniyoshi; Hiroyuki Sakuramoto; Kazutoshi Yoshitake; Kosuke Abe; Kazuho Ikeo; Masaaki Furuno; Kazushige Tsunoda; Shunji Kusaka; Yoshikazu Shimomura; Takeshi Iwata
Journal:  Doc Ophthalmol       Date:  2014-04-22       Impact factor: 2.379

3.  Pseudo-fovea formation after gene therapy for RPE65-LCA.

Authors:  Artur V Cideciyan; Geoffrey K Aguirre; Samuel G Jacobson; Omar H Butt; Sharon B Schwartz; Malgorzata Swider; Alejandro J Roman; Sam Sadigh; William W Hauswirth
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-12-23       Impact factor: 4.799

Review 4.  Clinical and genetic findings in a family with NMNAT1-associated Leber congenital amaurosis: case report and review of the literature.

Authors:  A Hedergott; A E Volk; P Herkenrath; H Thiele; J Fricke; J Altmüller; P Nürnberg; C Kubisch; A Neugebauer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-10-13       Impact factor: 3.117

5.  Genetic analysis of 10 pedigrees with inherited retinal degeneration by exome sequencing and phenotype-genotype association.

Authors:  Pooja Biswas; Jacque L Duncan; Bruno Maranhao; Igor Kozak; Kari Branham; Luis Gabriel; Jonathan H Lin; Giulio Barteselli; Mili Navani; John Suk; Michelle Parke; Catherine Schlechter; Richard G Weleber; John R Heckenlively; Gislin Dagnelie; Pauline Lee; S Amer Riazuddin; Radha Ayyagari
Journal:  Physiol Genomics       Date:  2017-01-27       Impact factor: 3.107

Review 6.  Leber's Congenital Amaurosis and Gene Therapy.

Authors:  Brijesh Takkar; Pooja Bansal; Pradeep Venkatesh
Journal:  Indian J Pediatr       Date:  2017-07-07       Impact factor: 1.967

7.  Using patient-specific induced pluripotent stem cells to interrogate the pathogenicity of a novel retinal pigment epithelium-specific 65 kDa cryptic splice site mutation and confirm eligibility for enrollment into a clinical gene augmentation trial.

Authors:  Budd A Tucker; Cathryn M Cranston; Kristin A Anfinson; Suruchi Shrestha; Luan M Streb; Alejandro Leon; Robert F Mullins; Edwin M Stone
Journal:  Transl Res       Date:  2015-08-29       Impact factor: 7.012

Review 8.  Optic disk drusen in children.

Authors:  Melinda Y Chang; Stacy L Pineles
Journal:  Surv Ophthalmol       Date:  2016-03-29       Impact factor: 6.048

9.  Phenotypic features of CRB1-associated early-onset severe retinal dystrophy and the different molecular approaches to identifying the disease-causing variants.

Authors:  Bohdan Kousal; Lubica Dudakova; Renata Gaillyova; Michaela Hejtmankova; Pavel Diblik; Michel Michaelides; Petra Liskova
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-25       Impact factor: 3.117

10.  A mutation in IFT43 causes non-syndromic recessive retinal degeneration.

Authors:  Pooja Biswas; Jacque L Duncan; Muhammad Ali; Hiroko Matsui; Muhammad Asif Naeem; Pongali B Raghavendra; Kelly A Frazer; Heleen H Arts; Sheikh Riazuddin; Javed Akram; J Fielding Hejtmancik; S Amer Riazuddin; Radha Ayyagari
Journal:  Hum Mol Genet       Date:  2017-12-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.